Efficacy and safety of selective nonsteroidal mineralocorticoid receptor antagonist finerenone in chronic kidney disease: a systematic review and meta-analysis of randomized clinical trials
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.